Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage

NCT01787123 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Subarachnoid Hemorrhage
Intracranial Aneurysm
Delayed Cerebral Ischemia
Delayed Ischemic Neurological Deficit

Interventions

DRUG: Intravenous Cerebrolysin
DRUG: Normal Saline

Sponsor

Kwong Wah Hospital